EUVIMEDEUVIMED entdecken
Crossref

Optimization and Validation of Glycerol-induced Acute Renal Failure Model in Rats in Predicting the Pharmacokinetics in Patients with Acute Renal Failure

Ramachandra Rao Sangana

Pharmacy and Drug Development · 2022

DOI: 10.58489/2836-2322/001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacy and Drug Development, 2022. Verfasst von Ramachandra Rao Sangana.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study standardized the glycerol induced (intra-peritoneal and intra-muscular) acute renal failure (ARF) models in Sprague-Dawley rats and validated its potential to predict the change in pharmacokinetics of the selected probe drugs in renal impairment. We assessed the induction of ARF by measuring the serum creatinine and blood-urea-nitrogen (BUN) levels at different time points (baseline, 6 h, 12 h, 24 h, 48 h and 72 h). Glycerol administrations via both intra-peritoneal and intra-muscular routes caused a significant increase in serum creatinine and BUN levels in rats at 6 h; however, the levels decreased within 24 h with intra-peritoneal administration. In contrast, with intra-muscular administration, a sustained increase in serum creatinine and BUN levels was observed up to 72 h post glycerol treatment demonstrating a sustained ARF like condition in rats that was suitable to evaluate the pharmacokinetics of drugs. Therefore, intra-muscular glycerol administration model was used to evaluate the pharmacokinetics of selected probe drugs including metformin, digoxin, atorvastatin and linezolid. The pharmacokinetics of metformin and digoxin were significantly altered in ARF versus control rats with increase in plasma exposure, prolonged elimination half-life and decreased systemic clearance. However, the pharmacokinetics of atorvastatin and linezolid did not show significant differences between ARF and control rats. These results demonstrated the utility of the ARF model in rats in predicting pharmacokinetic changes in patients with renal impairment. Such models may prove useful in early discovery work to screen and prioritize compounds requiring dose adjustment in patients with renal impairment.

Zitieren

APA

Sangana, R. R. (2022). Optimization and Validation of Glycerol-induced Acute Renal Failure Model in Rats in Predicting the Pharmacokinetics in Patients with Acute Renal Failure. Pharmacy and Drug Development. https://doi.org/10.58489/2836-2322/001

Vancouver

Sangana RR. Optimization and Validation of Glycerol-induced Acute Renal Failure Model in Rats in Predicting the Pharmacokinetics in Patients with Acute Renal Failure. Pharmacy and Drug Development. 2022. doi:10.58489/2836-2322/001

BibTeX
@article{Sangana2022,
  author = {Sangana, Ramachandra Rao},
  title = {Optimization and Validation of Glycerol-induced Acute Renal Failure Model in Rats in Predicting the Pharmacokinetics in Patients with Acute Renal Failure},
  journal = {Pharmacy and Drug Development},
  year = {2022},
  doi = {10.58489/2836-2322/001}
}
Kostenlos starten →